Skip to main content
Clinical Trials/DRKS00026656
DRKS00026656
Completed
Not Applicable

Analysis of differential gene and protein expression for the in vitro detection of drug allergy - INA = In vitro detection of drug allergy

Bundesinstitut für Arzneimittel und MedizinprodukteAbteilung Forschung0 sites57 target enrollmentOctober 8, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Drug allergy
Sponsor
Bundesinstitut für Arzneimittel und MedizinprodukteAbteilung Forschung
Enrollment
57
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 8, 2021
End Date
August 31, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Bundesinstitut für Arzneimittel und MedizinprodukteAbteilung Forschung

Eligibility Criteria

Inclusion Criteria

  • For patients: 1\) Clinically documented association and confirmed diagnosis (medical history, skin tests, in vitro diagnostics if applicable) of drug allergy (for development and validation of the in vitro test system) or suspected drug allergy (patients with
  • suspected but not yet conclusively confirmed drug allergy) 2\) Written and verbal consent to participate.

Exclusion Criteria

  • 1\) Lack of capacity to give consent to participate in the examination 2\) Lack of temporal connection and evidence 3\) Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials